Elderly donors? 50 is the new 60
James J. Pomposelli – 25 February 2011
James J. Pomposelli – 25 February 2011
Sang Won Park, Mihwa Kim, Kevin M. Brown, Vivette D. D'Agati, H. Thomas Lee – 25 February 2011 – Hepatic ischemia and reperfusion (IR) injury is a major clinical problem that leads to frequent extrahepatic complications including intestinal dysfunction and acute kidney injury (AKI). In this study we aimed to determine the mechanisms of hepatic IR‐induced extrahepatic organ dysfunction. Mice subjected to 60 minutes of hepatic IR not only developed severe hepatic injury but also developed significant AKI and small intestinal injury.
Kim M. Olthoff, Michael M. Abecassis, Jean C. Emond, Igal Kam, Robert M. Merion, Brenda W. Gillespie, Lan Tong, the Adult‐to‐Adult Living Donor Liver Transplantation Cohort Study Group – 25 February 2011 – The study objectives were to determine whether the findings of the Adult‐to‐Adult Living Donor Liver Transplantation Cohort Study (A2ALL) reflect the U.S. national experience and to define risk factors for patient mortality and graft loss in living donor liver transplantation (LDLT).
Rafael San‐Juan, Jose M. Aguado, Carlos Lumbreras, Jesus Fortun, Oscar Len, Patricia Munoz, Miguel Montejo, Asunción Moreno, Elisa Cordero, Marino Blanes, Antonio Ramos, Julian Torre‐Cisneros, Francisco López‐Medrano, Jordi Carratala, Enrique Moreno, for the Spanish Network of Infection in Transplantation/Spanish Network for Research in Infectious Diseases – 23 February 2011 – The role of selective intestinal decontamination with fluoroquinolones (FQ‐SID) in the prevention of early bacterial infections (EBIs) in liver transplant recipients (LTRs) is unknown.
Melania Manco, Cristina Lo Zupone, Alessandro Latini, Vincenzina Lucidi, Lidia Monti – 23 February 2011
Rita Golfieri, Alberta Cappelli, Alessandro Cucchetti, Fabio Piscaglia, Maria Carpenzano, Eugenia Peri, Matteo Ravaioli, Antonia D'Errico‐Grigioni, Antonio Daniele Pinna, Luigi Bolondi – 23 February 2011 – Transarterial chemoembolization (TACE) is commonly used as a bridge therapy for patients awaiting liver transplantation (LT) and for downstaging patients initially not meeting the Milan criteria.
Wolfram Haller, Jim Buttery, Karen Laurie, Kathe Beyerle, Winita Hardikar, George Alex – 23 February 2011 – After the announcement of a worldwide pandemic in June 2009, a single dose of a monovalent pandemic H1N1 2009 influenza A (pH1N1/09) vaccine was advocated for all Australians who were 10 years and older because of excellent immunogenicity trial results for healthy children and adults. Immunocompromised patients have previously been shown to have lower seroconversion rates after routine vaccinations.
James R. Rodrigue, William Balistreri, Barbara Haber, Maureen M. Jonas, Parvathi Mohan, Jean P. Molleston, Karen F. Murray, Michael R. Narkewicz, Philip Rosenthal, Lesley J. Smith, Steven J. Lobritto, Kathleen B. Schwarz, Patricia R. Robuck, Bruce Barton, Regino P. González‐Peralta – 23 February 2011 – The aim of this study was to prospectively assess the quality of life (QOL), behavioral/emotional functioning, and cognitive status of children undergoing treatment for hepatitis C virus (HCV) infection.
Natalie A. Molodecky, Hashim Kareemi, Rohan Parab, Herman W. Barkema, Hude Quan, Robert P. Myers, Gilaad G. Kaplan – 23 February 2011 – Incidence studies of primary sclerosing cholangitis (PSC) are important for describing the disease's burden and for shedding light on the disease's etiology. The purposes of this study were to conduct a systematic review of the incidence studies of PSC with a meta‐analysis and to investigate possible geographic variations and temporal trends in the incidence of the disease.